These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 22230447)
21. [Mechanisms of immune system contribution to efficiency of antitumor cytostatic therapy]. Stakheeva MN; Kzhyshkowska YG; Buldakov MA; Cherdyntseva NV Vopr Onkol; 2015; 61(4):546-55. PubMed ID: 26571821 [TBL] [Abstract][Full Text] [Related]
22. [Prospects for the use of plant polysaccharides in complex treatment of malignant tumors]. Safonova EA; Razina TG; Zueva EP; Lopatina KA; Efimova LA; Gur'ev AM; Rybalkina OIu; Khotimchenko IuS Eksp Klin Farmakol; 2012; 75(9):42-7. PubMed ID: 23156088 [TBL] [Abstract][Full Text] [Related]
23. Modeling and optimization of combined cytostatic and cytotoxic cancer chemotherapy. Villasana M; Ochoa G; Aguilar S Artif Intell Med; 2010 Nov; 50(3):163-73. PubMed ID: 20620035 [TBL] [Abstract][Full Text] [Related]
24. New cytotoxic agents. Piccart M Cancer Treat Rev; 1997 Jul; 23 Suppl 1():S59-67. PubMed ID: 9377603 [No Abstract] [Full Text] [Related]
29. Blood-brain barrier disruption in the treatment of brain tumors. Blanchette M; Fortin D Methods Mol Biol; 2011; 686():447-63. PubMed ID: 21082387 [TBL] [Abstract][Full Text] [Related]
30. Tea tree oil might combat melanoma. Bozzuto G; Colone M; Toccacieli L; Stringaro A; Molinari A Planta Med; 2011 Jan; 77(1):54-6. PubMed ID: 20560116 [TBL] [Abstract][Full Text] [Related]
31. Is cell death a critical end point for anticancer therapies or is cytostasis sufficient? Rixe O; Fojo T Clin Cancer Res; 2007 Dec; 13(24):7280-7. PubMed ID: 18094408 [TBL] [Abstract][Full Text] [Related]
32. [Experiences and results in combined radio-cytostatic treatment of operated glioblastomas]. Ott J; Richter HH Radiobiol Radiother (Berl); 1966; 7(6):739-42. PubMed ID: 5974348 [No Abstract] [Full Text] [Related]
36. Heading in a new direction: drug permeability in breast cancer brain metastasis. Sledge GW Clin Cancer Res; 2010 Dec; 16(23):5605-7. PubMed ID: 21045085 [TBL] [Abstract][Full Text] [Related]
37. Cancer therapy from bench to bedside. Oh WK; Burakoff SJ Mt Sinai J Med; 2010; 77(6):571-2. PubMed ID: 21105120 [No Abstract] [Full Text] [Related]
38. The targeted delivery of cancer drugs across the blood-brain barrier: chemical modifications of drugs or drug-nanoparticles? Juillerat-Jeanneret L Drug Discov Today; 2008 Dec; 13(23-24):1099-106. PubMed ID: 18848640 [TBL] [Abstract][Full Text] [Related]
39. [Letter: Combined cytostatic therapy of malignant brain tumors. Discussion contribution to W-D. Heiss, A. Kroiss, J. Kühböck, W. Profanter, Münch. med. Wschr. 116 (1974) 1957]. Ackermann G MMW Munch Med Wochenschr; 1975 May; 117(20):879. PubMed ID: 806005 [No Abstract] [Full Text] [Related]
40. Let's talk about cytotoxic chemotherapy dosing: unravelling adjustments and off-protocol prescribing. Tjokrowidjaja A; Hovey E; Lewis CR Med J Aust; 2019 Feb; 210(2):65-66. PubMed ID: 30712300 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]